Laura G. Eichorn - 02 Nov 2022 Form 4 Insider Report for Imago BioSciences, Inc.

Role: Chief Financial Officer
Signature: /s/ Hugh Y. Rienhoff, Jr., M.D., as Attorney-in-Fact for Laura G. Eichorn
Issuer symbol: N/A
Transactions as of: 02 Nov 2022
Net transactions value: -$8,560
Form type: 4
Filing time: 04 Nov 2022, 20:18:21 UTC
Previous filing: 24 Aug 2022
Next filing: 14 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMGO	Common Stock	Options Exercise	$1,394	+553	+0.27%	$2.52^*	208,290	02 Nov 2022	Direct	F1
transaction	IMGO	Common Stock	Sale	$9,954	-553	-0.27%	$18.00	207,737	02 Nov 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMGO	Stock Option (Right to Buy)	Options Exercise	$0	-553	-0.56%	$0.000000	99,050	02 Nov 2022	Common Stock	553	$2.52	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.